Amgen Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AMGN Nasdaq 2836 www.amgen.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amgen Inc.

2 Underrated Weight Loss Stocks to Buy and Hold - Jun 23rd, 2026 1:05 am
Willful Patent Infringement Verdict Might Change The Case For Investing In Amgen (AMGN) - Jun 22nd, 2026 6:13 pm
Stock Market Today: Dow Up As Bessent Makes This Iran Move; SpaceX Craters (Live Coverage) - Jun 22nd, 2026 2:31 pm
Abbvie acquiring Apogee for $10.9B, Coca-Cola vs. IRS in appeals court - Jun 22nd, 2026 1:47 pm
Amgen vs. NovoCure: Which Health Care Stock Is a Better Buy in 2026? - Jun 19th, 2026 11:10 am
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - Jun 19th, 2026 7:00 am
How One Partnership Profit Line Reframes The Regeneron Pharmaceuticals Stock Story - Jun 18th, 2026 6:56 pm
What If Amgen Stock's Patent Worries Are Hiding Its Real Growth Engine? - Jun 18th, 2026 2:57 pm
Amgen's Diversified Business, Emerging Pipeline Drives Positive View, RBC Says - Jun 18th, 2026 1:35 pm
Amgen (AMGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Jun 17th, 2026 3:50 pm
Eli Lilly Stock's Trillion-Dollar Question - Jun 17th, 2026 12:21 pm
Vedana debuts with $46m to progress migraine therapies - Jun 17th, 2026 10:39 am
Everyone Is Watching Eli Lilly Stock's New Drugs. Here Is the Metric That Vanished - Jun 17th, 2026 9:57 am
Harbour BioMed Secures Landmark Victory in U.S. Patent Infringement Case Against Amgen, Reshaping the Global Antibody Patent Landscape - Jun 14th, 2026 6:01 pm
Morgan Stanley Raises Amgen (AMGN) Price Target Following a Strong Start for Uplizna - Jun 13th, 2026 11:37 pm
Amgen Faces Dual Turning Point With IMDYLLTRA Gain And Tavneos Risk - Jun 13th, 2026 10:14 pm
Here’s Why Amgen (AMGN) is Among the 7 Best Longevity Stocks to Buy Now - Jun 13th, 2026 4:39 am
The Catch Hiding In Eli Lilly Stock's Growth Story - Jun 12th, 2026 11:31 am
Amgen's $500 Million Tavneos Faces FDA Withdrawal Fight - Jun 12th, 2026 7:09 am
AbbVie Reports Promising New Clinical Updates. Here's What It Means for the Company's Dividend. - Jun 12th, 2026 4:35 am